Efficacy evaluation of the combination therapy of sorafenib and transarterial chemoembolization for unresectable HCC: a systematic review and meta-analysis of comparative studies

BACKGROUND: Sorafenib and transarterial chemoembolization (TACE) are the standard treatments recommended by guidelines for unresectable hepatocellular carcinoma (HCC). Although previous studies have shown the combination therapy of sorafenib and TACE to be safe, there is no consensus regarding its e...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Huichen, Li, Songlun, Geng, Jie, Zhao, Shoujie, Tan, Kai, Yang, Zhenyu, Feng, Dayun, Liu, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214895/
https://www.ncbi.nlm.nih.gov/pubmed/32411763
http://dx.doi.org/10.21037/atm.2020.02.115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214895/
https://www.ncbi.nlm.nih.gov/pubmed/32411763
http://dx.doi.org/10.21037/atm.2020.02.115

Ejemplares similares